NIH-funded research NIH-funded research

Understanding how TGFβ affects immune responses in allergic diseases

Official title: TGFβ Restricts Tfh2 Differentiation but Augments IgE-Mediated Mast Cell Function: Critical and Opposing Roles in Allergic Disease

Funded at Indiana University Indianapolis · NIH-11032247 · Data updated 2026-11-12

This study is looking at how a specific protein called TGFβ affects certain immune cells and their role in allergies, especially in people with Loeys-Dietz Syndrome, to help find better ways to treat allergic reactions.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionIndiana University Indianapolis
NIH-funded
Lab location1 site (Indianapolis, United States)
Project startJune 18, 2025
Project endMay 31, 2027
Funding year2025
Award (this year)$162,000
NIH project number1K22AI187413-01
Project IDNIH-11032247 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with Loeys-Dietz Syndrome who experience allergies such as asthma, eczema, or food allergies.

Less likely to help

Patients without Loeys-Dietz Syndrome or those not suffering from allergic diseases may not benefit from this research.

What this research studies

This research investigates the role of TGFβ, a cytokine involved in immune regulation, in the differentiation of T follicular helper cells (Tfh) and the function of mast cells (MC) in allergic diseases. By studying patients with Loeys-Dietz Syndrome, who are prone to allergies, the research aims to uncover how disruptions in TGFβ signaling influence IgE production and allergic responses. The approach includes analyzing patient samples and using mouse models to explore the underlying mechanisms of allergic reactions. This could lead to new therapeutic targets for treating allergies.

Why it matters

Potential benefit: If successful, this research could lead to innovative treatments for patients suffering from allergic diseases.

How similar studies have gone: Other research has shown promising results in understanding immune responses related to TGFβ, indicating that this approach has potential for success.

Where this research is happening

  • Indiana University Indianapolis
    Indianapolis, United States
    Active

Researchers

  • Principal investigator: Haque, Tamara Tasmia — Indiana University Indianapolis
  • Study coordinator: Haque, Tamara Tasmia

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.